LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 59.42 | 21.74 | 755 | 6125 | 0.1233 | 0.5464 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 59.42 | 21.74 | 5209 | 6125 | 0.8504 | 0.9606 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 59.42 | 21.74 | 215 | 6125 | 0.0351 | 0.3252 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 59.42 | 21.74 | 5552 | 6125 | 0.9064 | 0.9760 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 62.39 | 21.74 | 877 | 6112 | 0.1435 | 0.5754 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 62.39 | 21.74 | 5575 | 6112 | 0.9120 | 0.9775 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 62.39 | 21.74 | 241 | 6112 | 0.0394 | 0.3441 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 62.39 | 21.74 | 5942 | 6112 | 0.9721 | 0.9931 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 64.36 | 21.74 | 1031 | 6191 | 0.1665 | 0.6053 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 64.36 | 21.74 | 6005 | 6191 | 0.9700 | 0.9925 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 64.36 | 21.74 | 171 | 6191 | 0.0276 | 0.2878 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 64.36 | 21.74 | 6411 | 6191 | 1.0355 | 1.0086 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 66.33 | 21.74 | 1141 | 6235 | 0.1830 | 0.6244 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 66.33 | 21.74 | 6446 | 6235 | 1.0337 | 1.0081 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 66.33 | 21.74 | 249 | 6235 | 0.0399 | 0.3481 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 66.33 | 21.74 | 6706 | 6235 | 1.0754 | 1.0179 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 68.30 | 21.74 | 1247 | 6244 | 0.1997 | 0.6419 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 68.30 | 21.74 | 6741 | 6244 | 1.0795 | 1.0188 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 68.30 | 21.74 | 323 | 6244 | 0.0517 | 0.3916 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 68.30 | 21.74 | 7131 | 6244 | 1.1419 | 1.0328 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.27 | 21.74 | 1346 | 6201 | 0.2170 | 0.6584 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.27 | 21.74 | 7138 | 6201 | 1.1509 | 1.0348 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.27 | 21.74 | 358 | 6201 | 0.0577 | 0.4098 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.27 | 21.74 | 7353 | 6201 | 1.1856 | 1.0422 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 72.24 | 21.74 | 1510 | 6162 | 0.2451 | 0.6829 | MN20160310_N01 | I13 |